09 September 2021 | News
Contributes to Ambix Life Science Fund, a U.S. Medical Device Venture Fund and reinforces overseas development in the healthcare field
Photo Credit: Freepik
TANAKA Kikinzoku Kogyo K.K. which is a subsidiary of TANAKA Holdings Co., Ltd. and operates the TANAKA Precious Metals manufacturing business, has made an equity contribution to Ambix Life Science Fund I, L.P., a medical device venture fund managed by Ambix Venture Management, LLC, a U.S.-based venture capital management company.
Through this equity contribution, TANAKA will reinforce its overseas business development in addition to its domestic business development and contribute to the development of a safe and secure healthcare industry.
TANAKA provides precious metal components and materials to medical device manufacturers and participates in development projects, cooperating with and contributing to development in the healthcare field. In addition, the company has made equity contributions to multiple medical device venture funds in the past and made the decision at this time to make a contribution to the venture fund of Ambix Ventures, which is based in Silicon Valley, one of the centers of medical device innovation, in order to provide even greater support to the development of the healthcare industry.
TANAKA seeks to strengthen its ties with the U.S. healthcare industry and contribute to the progress of cutting-edge healthcare through the use of precious metal components and materials in the healthcare field by making an equity contribution to the fund, which is managed by Aaron Berez, MD, a leading entrepreneur in the healthcare industry, and Peter N. Townshend.